When compounded, semaglutide and L-Carnitine are combined into one weekly injection
Since GLP-1s can reduce stomach acid and slow absorption, B12 levels can drop even further
Patients should tell their doctor if each dose increase brings stronger nausea, fatigue, reflux, constipation, or inability to eat
The medication is typically prescribed when diet and exercise alone, or in combination with other oral antidiabetic agents such as metformin, have not achieved adequate glycaemic control
Specifically, Rybelsus (oral semaglutide) has been shown to lower A1C by about 1.0% to 1.5%, while Foundayo (orforglipron) reported average A1C reductions ranging from about 1.2% to 1.7% depending on the dose